Investing.com - Financial Markets Worldwide

Kiniksa Pharmaceuticals Ltd (KNSA)

NASDAQ
Symbol
Exchange
Currency
11.41
+0.18(+1.60%)
-Closed.
Currency in USD
After Hours
11.41
0.00(0.00%)
- Real-time Data
  • Volume:
    232,554
  • Day's Range:
    10.76 - 11.47
  • 52 wk Range:
    7.36 - 17.19

KNSA Comments

What is your sentiment on Kiniksa Pharma?
or
Market is currently closed. Voting is open during market hours.

All Comments

(3)
  • I'm surprised no activity there is little activity on this stock.
    0
    • The FDA has approved. - ARCALYST is the first and only FDA-approved therapy for recurrent pericarditis- Commercial launch expected in April 2021- Kiniksa launches Kiniksa One Connect™ patient support program
      0
      • Breakthrough Therapy designation granted by the FDA for rilonacept for the treatment of recurrent pericarditis, due date is 21st March 2021 under priority review.That should help some movement
        0